Outcomes in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for maximal volume (PCI 39) appendiceal tumours

Sarkar, Amit; Lansom, Joshua; Dey, Anindita; Fisher, Oliver M.; Alzahrani, Nayef; Morris, D. L.

doi:10.1016/j.ejso.2020.11.138

Search citation statements

Order By: Relevance

Paper Sections

Select...

High Grade High Peritoneal Carcinomatosis Index1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

2024

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indeed, even patients with extensive carcinomatosis and high-grade tumors may benefit from CRS/HIPEC. 78,87 Strict application of PCI cutoffs are difficult to define; these patients should always be evaluated by experienced surgeons and teams familiar with the disease when assessing the utility of CRS/HIPEC.…”

Section: High Grade High Peritoneal Carcinomatosis Indexmentioning

confidence: 99%

Current Management of Appendiceal Neoplasms

Hoehn

Rieser

Choudry

et al. 2021

American Society of Clinical Oncology Educational Book

View full text Add to dashboard Cite

Appendiceal neoplasms include a heterogeneous group of epithelial and nonepithelial tumors that exhibit varying malignant potential. This review article summarizes current diagnostic criteria, classification systems, and optimal therapeutic strategies for the five main histopathologic subtypes of appendiceal neoplasms. In particular, the management of epithelial appendiceal neoplasms has evolved. Although their treatment has historically been extrapolated from colon cancer, improved understanding of their unique histopathologic and molecular characteristics and a growing body of published clinical data support a more nuanced approach to their management.

show abstract

Section: High Grade High Peritoneal Carcinomatosis Indexmentioning

confidence: 99%